Skip to content
lsd.com

Indication

Multiple Sclerosis, Relapsing-Remitting

2 registered trials testing DMT for this indication, none currently recruiting.

Sponsors register this under 2 different names, all collected here: Multiple Sclerosis, Relapsing-Remitting · Relapsing Remitting Multiple Sclerosis

2
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Multiple Sclerosis, Relapsing-Remitting trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Multiple Sclerosis, Relapsing-Remitting

TrialStatusPhaseSubstanceSites
Tecfidera and the Gut MicrobiotaNCT02471560 · BiogenCompletedPhase 4dmt7
Cladribine Tablets as an Exit Therapy StrategyNCT06887426 · University Hospital, Strasbourg, FranceNot yet recruitingN/Admt1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.